fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Scientists develop breath test that rapidly detects COVID-19 virus

Written by | 4 Aug 2023

Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires… read more.

CHMP recommends Abrysvo the first RSV vaccine to protect infants up to 6 months of age and older adults – Pfizer

Written by | 31 Jul 2023

The CHMP has recommended granting a marketing authorization for Pfizer’s Abrysvo (bivalent, recombinant), a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is… read more.

Bacterial test for pediatric sinusitis could ease diagnosis and reduce overuse of antibiotics

Written by | 27 Jul 2023

Among children suspected of having sinusitis, a swabbing for three types of bacteria can determine whether antibiotics are likely to be an effective treatment. The finding were published… read more.

Omega-3 fatty acids appear promising for maintaining lung health

Written by | 26 Jul 2023

Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising for maintaining lung health, according to new evidence from a large, multi-faceted study in… read more.

CHMP recommends Lyfnua as a treatment for refractory or unexplained chronic cough – Merck Inc

Written by | 25 Jul 2023

Merck Inc., known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)… read more.

Vaping a gateway to smoking for non-smokers, research shows

Written by | 12 Jul 2023

While vaping provides a pathway to help smokers wanting to quit, for non-smokers it may be the first step on a pathway to taking up smoking, a new… read more.

EU approves Arexvy for respiratory syncytial virus – GSK

Written by | 11 Jun 2023

GSK announced that the European Commission has authorised Arexvy (respiratory syncytial virus vaccine, adjuvanted) for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by… read more.

Cancer survivors who quit smoking have 36% lower cardiovascular risk than continuers

Written by | 2 Jun 2023

Cancer patients who continue smoking after their diagnosis have a nearly doubled risk of heart attack, stroke or death due to cardiovascular disease compared with non-smokers, according to… read more.

Artificial intelligence can help categorize and triage primary care patients with respiratory symptoms

Written by | 25 May 2023

Researchers from Iceland trained a machine learning model with artificial intelligence to triage patients with respiratory symptoms before the patients visit a primary care clinic. To train the… read more.

Experts call for monitoring of respiratory vaccine after trials suggest possible increase in preterm births

Written by | 15 May 2023

Experts have called for further scrutiny of a new Pfizer vaccine given during pregnancy to prevent respiratory infection in infants, after trials of a similar GSK vaccine were stopped… read more.

Restricting flavored e-cigarettes may reduce their use among teens and young adults

Written by | 5 May 2023

Getting many adolescents and young adults to stop using e-cigarettes may be as simple as doing away with flavored versions of the product, according to new research in… read more.

How vitamin D3 helps allergic asthma

Written by | 1 May 2023

A vitamin D3 deficiency can lead to severe symptoms, for example in people suffering from allergic asthma. This has already been shown in several studies. However, we still… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.